| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Inotiv Inc (NASDAQ: NOTV)
NOTV Technical Analysis
5
| As on 9th Jun 2023 NOTV STOCK Price closed @ 5.45 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 21.58 & Strong Sell for SHORT-TERM with Stoploss of 32.67 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NOTVSTOCK Price
| Open | 5.51 | Change | Price | % |
| High | 5.57 | 1 Day | -0.03 | -0.55 |
| Low | 5.32 | 1 Week | -1.10 | -16.79 |
| Close | 5.45 | 1 Month | 0.30 | 5.83 |
| Volume | 230661 | 1 Year | -36.76 | -87.09 |
| 52 Week High 45.44 | 52 Week Low 3.77 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NOTV Daily Charts |
NOTV Intraday Charts |
Whats New @ Bazaartrend |
NOTV Free Analysis |
|
|
NOTV Important Levels Intraday
| RESISTANCE | 5.93 |
| RESISTANCE | 5.78 |
| RESISTANCE | 5.68 |
| RESISTANCE | 5.59 |
| SUPPORT | 5.31 |
| SUPPORT | 5.22 |
| SUPPORT | 5.12 |
| SUPPORT | 4.97 |
NOTV Forecast April 2024
| 4th UP Forecast | 40.35 |
| 3rd UP Forecast | 29.16 |
| 2nd UP Forecast | 22.24 |
| 1st UP Forecast | 15.32 |
| 1st DOWN Forecast | -4.42 |
| 2nd DOWN Forecast | -11.34 |
| 3rd DOWN Forecast | -18.26 |
| 4th DOWN Forecast | -29.45 |
NOTV Weekly Forecast
| 4th UP Forecast | 16.70 |
| 3rd UP Forecast | 13.09 |
| 2nd UP Forecast | 10.86 |
| 1st UP Forecast | 8.63 |
| 1st DOWN Forecast | 2.27 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | -2.19 |
| 4th DOWN Forecast | -5.80 |
NOTV Forecast2024
| 4th UP Forecast | 86.96 |
| 3rd UP Forecast | 60.82 |
| 2nd UP Forecast | 44.66 |
| 1st UP Forecast | 28.5 |
| 1st DOWN Forecast | -17.6 |
| 2nd DOWN Forecast | -33.76 |
| 3rd DOWN Forecast | -49.92 |
| 4th DOWN Forecast | -76.06 |
Inotiv Inc ( NASDAQ USA Symbol : NOTV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NOTV Business Profile
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana. Address: 2701 Kent Avenue, West Lafayette, IN, United States, 47906
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service